Swipe om te navigeren naar een ander artikel
Machine learning (ML) allows the exploration and progressive improvement of very complex high-dimensional data patterns that can be utilised to optimise specific classification and prediction tasks, outperforming traditional statistical approaches. An enormous acceleration of ready-to-use tools and artificial intelligence (AI) applications, shaped by the emergence, refinement, and application of powerful ML algorithms in several areas of knowledge, is ongoing. Although such progress has begun to permeate the medical sciences and clinical medicine, implementation in cardiovascular medicine and research is still in its infancy.
To lay out the theoretical framework, purpose, and structure of a novel AI consortium.
We have established a new Dutch research consortium, the CVON-AI, supported by the Netherlands Heart Foundation, to catalyse and facilitate the development and utilisation of AI solutions for existing and emerging cardiovascular research initiatives and to raise AI awareness in the cardiovascular research community. CVON-AI will connect to previously established CVON consortia and apply a cloud-based AI platform to supplement their planned traditional data-analysis approach.
A pilot experiment on the CVON-AI cloud was conducted using cardiac magnetic resonance data. It demonstrated the feasibility of the platform and documented excellent correlation between AI-generated ventricular function estimates as compared to expert manual annotations. The resulting AI solution was then integrated in a web application.
CVON-AI is a new consortium meant to facilitate the implementation and raise awareness of AI in cardiovascular research in the Netherlands. CVON-AI will create an accessible cloud-based platform for cardiovascular researchers, demonstrate the clinical applicability of AI, optimise the analytical methodology of other ongoing CVON consortia, and promote AI awareness through education and training.
Timmis A, Townsend N, Gale C, et al European Society of Cardiology. Cardiovascular Disease Statistics. Eur Heart J. 2017;2018(39):508–79.
Jaarverslag NTS. from. 2016. https://www.hartstichting.nl/getmedia/fa6e7f7b-f450-43f0-bafd-a96d0e66354c/jaarverslag-hartstichting-2016.pdf.
Topics on the research agenda June 2014 Earlier recognition of cardiovascular disease. Better treatment of heart failure and arrhythmias. 2014. Available from: https://www.hartstichting.nl/getmedia/f0adcaf8-ead6-452d-abee-c4fb638bf4e2/wetenschappers-hartstichting-onderzoeksagenda-engels.pdf.
Definition of artificial intelligence. Oxford dictionaries. Available from: https://en.oxforddictionaries.com/definition/artificial_intelligence.
Deo RC. Machine learning in medicine. Circulation. 2015;132:1920–30. CrossRef
Juarez-Orozco LE, Martinez-Manzanera O, Nesterov SV, Kajander S, Knuuti J. The machine learning horizon in cardiac hybrid imaging. Eur J Hybrid Imaging. 2018;2:15. https://ejhi.springeropen.com/articles/10.1186/s41824-018-0033-3. CrossRef
Obermeyer Z, Emanuel EJ. Predicting the future - big data, machine learning, and clinical medicine. N Engl J Med. 2016;375:1216–9. CrossRef
Silver D, Schrittwieser J, Simonyan K, et al. Mastering the game of Go without human knowledge. Nature. 2017;550:354–9. CrossRef
Abadi M, Agarwal A, Barham P, et al. TensorFlow: large-scale machine learning on heterogeneous systems. 2015; Available from: http://tensorflow.org.
Jia Y, Shelhamer E, Donahue J, et al. Caffe: convolutional architecture for fast feature embedding. arXiv Prepr. arXiv1408.5093 2014. https://doi.org/10.1145/2647868.2654889.
Seide F, Agarwal A. CNTK: Microsoft’s open-source deep-learning toolkit. In: Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining. New York: ACM; 2016. page 2135. Available from: http://doi.acm.org/10.1145/2939672.2945397.
Gulshan V, Peng L, Coram M, et al. Development and validation of a deep learning algorithm for detection of diabetic retinopathy in retinal fundus photographs. JAMA. 2016;316:2402–10. CrossRef
Esteva A, Kuprel B, Novoa RA, et al. Dermatologist-level classification of skin cancer with deep neural networks. Nature. 2017;542:115–8. CrossRef
FDA News Release. FDA permits marketing of artificial intelligence-based device to detect certain diabetes-related eye problems. 2018;1:17–9. Available from: https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm604357.htm.
Definition of the cloud. Oxford dictionaries. Available from: https://en.oxforddictionaries.com/definition/cloud.
Juarez-Orozco LE, Knol RJJ, Sanchez-Catasus CA, Martinez-Manzanera O, van der Zant FM, Knuuti J. Machine learning in the integration of simple variables for identifying patients with myocardial ischemia. J Nucl Cardiol. 2018; https://doi.org/10.1007/s12350-018-1304-x.
Lexis CPH, van der Horst ICC, Lipsic E, et al. Metformin in non-diabetic patients presenting with ST elevation myocardial infarction: rationale and design of the Glycometabolic Intervention as Adjunct to Primary Percutaneous Intervention in ST Elevation Myocardial Infarction (GIPS)-III Trial. Cardiovasc Drugs Ther. 2012;26:417–26. CrossRef
Ronneberger O, Fischer P, Brox T. U-Net: convolutional networks for biomedical image segmentation. BT - Medical Image Computing and Computer-Assisted Intervention – MICCAI 2015. 2015;234–41.
- Enhancing cardiovascular artificial intelligence (AI) research in the Netherlands: CVON-AI consortium
J. W. Benjamins
K. van Leeuwen
H. M. den Ruijter
F. W. Asselbergs
L. E. Juarez-Orozco
P. van der Harst
- Bohn Stafleu van Loghum